Cumberland Pharmaceuticals (CPIX) Gains from Investment Securities (2018 - 2025)
Historic Gains from Investment Securities for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Q3 2025 value amounting to $9651.0.
- Cumberland Pharmaceuticals' Gains from Investment Securities rose 10195.46% to $9651.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$431503.0, marking a year-over-year increase of 6318.86%. This contributed to the annual value of -$1.5 million for FY2024, which is 1650.64% down from last year.
- Cumberland Pharmaceuticals' Gains from Investment Securities amounted to $9651.0 in Q3 2025, which was up 10195.46% from $38602.0 recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Gains from Investment Securities ranged from a high of $5.6 million in Q4 2022 and a low of -$983574.0 during Q3 2022
- Moreover, its 5-year median value for Gains from Investment Securities was -$230430.0 (2024), whereas its average is $126432.1.
- In the last 5 years, Cumberland Pharmaceuticals' Gains from Investment Securities skyrocketed by 79241.13% in 2022 and then plummeted by 17224.37% in 2023.
- Over the past 5 years, Cumberland Pharmaceuticals' Gains from Investment Securities (Quarter) stood at $632319.0 in 2021, then surged by 792.41% to $5.6 million in 2022, then crashed by 104.18% to -$236128.0 in 2023, then plummeted by 122.22% to -$524732.0 in 2024, then soared by 101.84% to $9651.0 in 2025.
- Its Gains from Investment Securities was $9651.0 in Q3 2025, compared to $38602.0 in Q2 2025 and $44976.0 in Q1 2025.